Articles

Indiana’s insurance exchanges are pricey

The premiums offered by health insurers participating in the Obamacare exchanges put Indiana among the 10 most-expensive states in the country, according to data released last month by the U.S. Department of Health and Human Services.

Read More

Analysts: Investors wrong to dump Endocyte

Investors on Friday dumped shares of West Lafayette-based Endocyte Inc. after an independent analysis said an experimental lung cancer drug is unlikely to be declared superior to existing chemotherapy. But two analysts say, to the contrary, the analysis shows the prospects for Endocyte’s drug are as good as ever.

Read More

Finding where the money is in health care

More than half of the $2.5 trillion consumers spend annually on health care in the United States flows to hospitals and doctors, with drug companies and health insurers trailing well behind.

Read More

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More

City officials aim to build on momentum for cycling

Indianapolis has become a more bike-friendly city, and city planners are looking to ensure the progress continues. The Metropolitan Development Commission will vote Oct. 16 on a bicycle master plan that lays out a host of educational and policy initiatives to encourage two-wheeled transportation.

Read More

Financial pressures stretching Lilly

In a series of presentations, Lilly executives stretched themselves in four directions at once to convince investors and stock analysts that the company will bend but not break next year, and then snap back stronger than ever in 2015.

Read More

Gene Glick was a soldier, a builder and a philanthropic giant

Gene Biccard Glick, who died at home following a long battle with Alzheimer’s disease, built affordable housing sprawling across 10 states—a business empire that paved the way for tens of millions of dollars in donations to causes ranging from medicine to recreation.

Read More

Lilly to buy back $5B as sales goal harder to reach

Eli Lilly and Co. said Thursday that meeting its sale target will be a challenge. It plans to repurchase $5 billion in shares and introduce new diabetes drugs to help navigate through patent losses. Another immediate hurdle: Obamacare.

Read More

Pressure mounts to fix health insurance exchanges

The pressure is on for the federal government and states running their own health insurance exchanges to get the systems up and running after overloaded websites and jammed phone lines frustrated consumers for a second day.

Read More